Advertisement
Singapore markets closed

  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • Dow

    38,460.92
    -42.77 (-0.11%)
     

  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     

  • Bitcoin USD

    63,728.16
    -2,870.85 (-4.31%)
     

  • CMC Crypto 200

    1,360.26
    -22.31 (-1.61%)
     

  • FTSE 100

    8,097.48
    +57.10 (+0.71%)
     

  • Gold

    2,341.50
    +3.10 (+0.13%)
     

  • Crude Oil

    82.98
    +0.17 (+0.21%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     

  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     

  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     

  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     

  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Celgene stock edges higher amid $3 billion buyback announcement

Celena Chong
Updated

Celgene (NASDAQ: CELG) shares were slightly higher Wednesday after the company authorized a repurchase of up to an additional $3 billion of its common stock.

Shares of Celgene later reversed and ended the day 1 percent lower.

"Celgene now has a total of approximately $5.3 billion available from previous authorizations plus the new authorization," the biopharmaceutical giant said in a release, adding it has funneled approximately $15.2 billion to its shareholders through this open-ended program since 2009.

The New Jersey-based company's stock has tumbled 16 percent this year. It fell below $100 Wednesday, closing at $99.98.

CELG year to date




More From CNBC

  • Top News and Analysis

  • Latest News Video

  • Personal Finance